For this discussion, I have selected the interactive media piece “Treating Major Depressive Disorder.” Major depressive disorder (MDD) is a mood disorder that is characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in activities.
In completing the interactive media piece for MDD, the decision steps I applied included identifying the patient’s symptoms, assessing their severity, determining their past medication history and comorbidities, and selecting an appropriate pharmacotherapeutic.
Based on the patient’s symptoms and medical history, I recommended the use of a selective serotonin reuptake inhibitor (SSRI) as the most effective pharmacotherapeutic. SSRIs increase the brain’s levels of serotonin, which regulates sleep and mood.
The administration of an SSRI may impact the patient’s pathophysiology in several ways. First, SSRIs can lead to changes in the brain’s chemistry by altering the levels of neurotransmitters such as serotonin. This could lead to a decrease in depression symptoms. Side effects of SSRIs can include nausea, dizziness and sexual dysfunction.
It is crucial to assess the possible effects of pharmacotherapeutics upon the patient’s pathophysiology before recommending treatment. Alternative medications, or other therapies, may be offered if there are side effects from SSRIs. Additionally, ongoing monitoring of the patient’s symptoms and any potential adverse effects associated with pharmacotherapeutics is essential to ensure the patient receives safe and effective treatment.